NEW YORK (TheStreet) -- CHANGE IN RATINGS
( CEPH) downgraded at BofA/Merrill to Neutral from Buy on valuation. Maintain $75 price target. 2010 and 2011 EPS estimates held at $6.52 and $6.70, respectively.
( CEPH) target raised at UBS to $80. Company is seeing better prescription trends. Buy rating.
DuPont Fabros Technology
initiated at Barclays with an Overweight rating and $25 price target. 2010 and 2011 EPS estimates set at $1.24 and $1.60, respectively.
upgraded at FBR from Market Perform to Outperform. Company is likely seeing an improved business pipeline. $36 price target.
Fresh Del Monte
downgraded at Suntrust from Buy to Neutral. See few meaningful catalysts on the horizon.
Public Service Enterprise
rated new Neutral at Goldman. $34 price target. Earnings growth in the regulated business will likely be offset by lower merchant generation results.
downgraded at Piper Jaffray. Rating lowered to Underweight from Neutral. Price target raised to $30 from $24. Maintains 2010 EPS estimates of $2.30.
downgraded at Wells to Market Perform. Company lowered guidance as it's seeing award delays.
upgraded at BMO from Market Perform to Outperform. $75 price target.
STOCK COMMENTS / EPS CHANGES
estimates higher at Credit Suisse after positive analyst day. 2010 and 2011 EPS estimates improved to $0.75 and $1.00, respectively. Maintain Neutral rating and $15.50 target.
numbers boosted at UBS. Estimates were increased through 2011. Company is seeing higher demand across the board. Buy rating and new $18 price target.
estimates raised at Morgan Stanley. CLF estimates were increased through 2011. Company will benefit from higher iron ore prices. Equal-weight rating.
estimates raised at Morgan Stanley through 2011. Company is positioned to benefit from higher copper prices. Equal-weight rating.
target, estimates boosted at Barclays. GRMN price target increased by dollar to $34 on strong PND growth. 2010 EPS estimate raised to $2.97, 2011 held at $2.75. Maintain Equal Weight rating.
numbers lowered at KBW. Shares of GS now seen reaching $195. Estimates also reduced, as the company likely saw lower investment banking revenue this quarter.
numbers upped at Morgan Stanley. Shares of ICE now seen reaching $118. Estimates also raised, as the company should benefit from higher OTC and energy volumes. Equal-weight rating.
estimates upped at FBR. LLTC estimates were raised through 2011. Checks suggest that quarterly sales are tracking at the high end of expectations. Underperform rating and $31 price target.
price target higher at Barclays. MDR price target jumped to $33 from $29 on improving prospects. 2010 and 2011 EPS estimates held at $1.85 and $2.15, respectively.
numbers raised at FBR. Shares of MXIM now seen reaching $23. Estimates also increased, following robust channel checks. Market Perform rating.
estimates lowered at Morgan Stanley through 2011. Company likely seeing lower volumes and losing market share. Equal-weight rating and $31 price target.
numbers boosted at Goldman. Shares of TGT now seen reaching $53. Estimates also upped, given improving credit trends. Neutral rating.
This article was written by a staff member of TheStreet.com.